Cutler Group’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,500
| Closed | -$28K | – | 2431 |
|
|
2019
Q3 | $28K | Buy |
+1,500
| New | +$28K | ﹤0.01% | 978 |
|
|
2018
Q2 | – | Sell |
-1,160
| Closed | -$14K | – | 2532 |
|
|
2018
Q1 | $14K | Sell |
1,160
-8,541
| -88% | -$103K | ﹤0.01% | 1303 |
|
|
2017
Q4 | $111K | Sell |
9,701
-6,324
| -39% | -$72.4K | ﹤0.01% | 808 |
|
|
2017
Q3 | $196K | Sell |
16,025
-26,945
| -63% | -$330K | 0.01% | 763 |
|
|
2017
Q2 | $492K | Buy |
42,970
+36,089
| +524% | +$413K | 0.02% | 504 |
|
|
2017
Q1 | $143K | Sell |
6,881
-6,002
| -47% | -$125K | 0.01% | 982 |
|
|
2016
Q4 | $267K | Buy |
12,883
+7,811
| +154% | +$162K | 0.01% | 731 |
|
|
2016
Q3 | $166K | Sell |
5,072
-3,019
| -37% | -$98.8K | 0.01% | 864 |
|
|
2016
Q2 | $202K | Buy |
8,091
+1,743
| +27% | +$43.5K | 0.01% | 685 |
|
|
2016
Q1 | $155K | Buy |
6,348
+915
| +17% | +$22.3K | 0.01% | 714 |
|
|
2015
Q4 | $179K | Buy |
+5,433
| New | +$179K | 0.01% | 768 |
|